Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 2 February 2026

Johnson & Johnson stock rises as new Erleada survival data lands

Johnson & Johnson stock rises as new Erleada survival data lands

Johnson & Johnson shares rose 0.8% to $229.09 midday after the company reported real-world data showing Erleada cut the risk of death by 51% over 24 months versus darolutamide in advanced prostate cancer. The move tracked broader U.S. market gains. Investors await further feedback from doctors and insurers, and key dates including a Feb. 24 ex-dividend.
2 February 2026
·····
Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Freeport-McMoRan shares rebounded 1.1% to $60.88 by midday after an early drop, as copper futures slid over 3% on both COMEX and LME. Metals sold off after Donald Trump named Kevin Warsh to replace Jerome Powell at the Fed, fueling rate concerns. CME Group raised margin requirements for metal futures. U.S. ISM manufacturing PMI rose to 52.6 in January, with new orders at 57.1.
2 February 2026
···
GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova shares rose 3.6% to $752.44 Monday after launching a senior notes offering to help fund its $5.3 billion acquisition of the remaining Prolec GE stake. The company has not disclosed the size or maturity of the bonds. Proceeds will also support general corporate needs. Investors are watching for pricing details and confirmation the Prolec deal closes as scheduled.
2 February 2026
······
Walmart stock pops as cross-border shipping push takes shape under new CEO

Walmart stock pops as cross-border shipping push takes shape under new CEO

Walmart shares rose 3.4% to $123.22 by midday Monday after announcing a “Walmart Exports” service for U.S. marketplace sellers to reach buyers in Mexico and Canada. The company named John Furner as CEO, replacing Doug McMillon. Investors await details on costs and rollout ahead of Walmart’s Feb. 19 earnings report. Trading volume reached 8.4 million shares.
2 February 2026
····
Unity stock rebounds as Google’s “Project Genie” jitters ease — what investors watch next

Unity stock rebounds as Google’s “Project Genie” jitters ease — what investors watch next

Unity shares rose 3.2% to $30.04 Monday, rebounding after last week’s 24% plunge triggered by Google’s launch of an AI world-generation tool. Analysts remain split on whether AI tools threaten demand for Unity’s game engine. Benchmark maintained its hold rating, citing risks from “world model” tech. Investors await Unity’s earnings on Feb. 11 for management’s view on AI and advertising trends.
2 February 2026
·····
Lumentum stock (Nasdaq: LITE) jumps 13% as earnings day nears

Lumentum stock (Nasdaq: LITE) jumps 13% as earnings day nears

Lumentum shares jumped 13.1% to $443.13 by midday Monday after hitting $448.24, ahead of fiscal Q2 earnings due Tuesday after the close. The company forecast Q2 revenue of $630 million to $670 million and a non-GAAP operating margin of 20% to 22%. Morgan Stanley raised its price target to $350 but kept an equal-weight rating. Trading volume reached about half the three-month average.
2 February 2026
····
ServiceNow stock price rebounds as software shares steady, buyback back in focus

ServiceNow stock price rebounds as software shares steady, buyback back in focus

ServiceNow shares climbed 3.7% to $121.33 on Monday, rebounding after last week’s sector slide and outpacing tech peers. The company recently reported Q4 subscription revenue of $3.47 billion and announced an imminent $2 billion accelerated buyback. Investors are watching for demand signals as the buyback and AI partnerships develop. Salesforce and Adobe also rose, while Microsoft slipped.
2 February 2026
······
Eli Lilly stock price climbs as obesity-drug forecasts get a reality check before earnings

Eli Lilly stock price climbs as obesity-drug forecasts get a reality check before earnings

Eli Lilly shares rose 1.5% to close near $1,052.70 Monday, recovering from early losses ahead of its earnings report due Wednesday. Analysts have cut long-term forecasts for obesity drugs as prices fall and competition intensifies, with 2030 sales estimates for GLP-1 drugs dropping to about $100 billion. Investors are focused on Lilly’s pricing strategy and demand outlook. The FDA is set to rule on Lilly’s weight-loss pill by April 10.
2 February 2026
·····
1 … 118 119 120 121 122 … 1,921

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop